Wikidata

(Q42666627)

English

The Rilutek (riluzole) Global Early Access Programme: an open-label safety evaluation in the treatment of amyotrophic lateral sclerosis

scientific article published on September 2001

In more languages

Statements

title
The Rilutek (riluzole) Global Early Access Programme: an open-label safety evaluation in the treatment of amyotrophic lateral sclerosis (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
11771772
retrieved
4 November 2017
publication date
1 September 2001
1 reference
stated in
Europe PubMed Central
PubMed ID
11771772
retrieved
4 November 2017
page(s)
153-158
1 reference
stated in
Europe PubMed Central
PubMed ID
11771772
retrieved
4 November 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q42666627&oldid=2046560442"